Medisch Centrum Leeuwarden
In research, Medisch Centrum Leeuwarden stands highest in Medicine (#3,017 of 10,443 worldwide) and Health Sciences (#4,043 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 6.1× its share of world research.
- World rank, 2022–2025
- #13,115 of 28,054 · #13,236 all time
- Rank in Netherlands
- #113 of 237
- Research works
- 1.2k ▲ 5% vs 2013–17
- Citations
- 23k 19.4 per fractional work
- Top-10% rate
- 17.6% record average 16.5%
- Open access
- 42% world 28%
What is Medisch Centrum Leeuwarden known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,017 of 10,443 | 18.8% | 134 | #2950 | |
| Health SciencesDomain | #4,043 of 11,982 | 18.6% | 144 | #3810 |
Each strip is that field’s whole ranked pool, with the notch where Medisch Centrum Leeuwarden sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Medisch Centrum Leeuwarden specialise in?
Where its research is concentrated relative to its size: Surgery takes 6.1× the share of its output that it takes of world research.
- SurgerySubfield · 26.3 works6.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Immunology and Microbiology 1.6×
- Nursing 1.6×
- Health Professions 1.5×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Neuroscience 0.8×
- Dentistry 0.7×
- Psychology 0.6×
- Economics, Econometrics and Finance 0.5×
- Veterinary 0.4×
- Arts and Humanities 0.3×
- Chemical Engineering 0.3×
- Engineering 0.3×
- Social Sciences 0.2×
- Computer Science 0.2×
- Earth and Planetary Sciences 0.1×
- Energy 0.1×
- Materials Science 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.1×
- Decision Sciences 0.1×
- Mathematics 0.0×
- Chemistry 0.0×
Who are the top researchers at Medisch Centrum Leeuwarden?
Ranked on the composite score, Michaël Kuiper, Sjoerd H. Hofma and Matty Koopmans lead among researchers whose main affiliation is Medisch Centrum Leeuwarden.
- 1 Michaël Kuiper Netherlands · #58,956 worldwide 615 citations · 27 works
- 2 Sjoerd H. Hofma Netherlands · #77,470 worldwide 890 citations · 24 works
- 3 Matty Koopmans Netherlands · #156,144 worldwide 415 citations · 19 works
- 4 Anneke Ten Brinke Netherlands · #158,007 worldwide 88 citations · 34 works
- 5 E. Christiaan Boerma Netherlands · #276,436 worldwide 116 citations · 19 works
- 6 A. Bakker Netherlands · #332,727 worldwide 65 citations · 26 works
- 7 J.Th. Planten Netherlands · #341,724 worldwide 11 citations · 24 works
- 8 Ad J. van Boven Netherlands · #417,058 worldwide 76 citations · 18 works
- 9 Reinhard Bos Netherlands · #444,916 worldwide 74 citations · 18 works
- 10 Eric N. van Roon Netherlands · #481,032 worldwide 20 citations · 35 works
Which keywords describe research at Medisch Centrum Leeuwarden?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Inflammation, Complications, Diagnosis, Quality of Life, Clinical Practice Guidelines and Cardiovascular Risk.
- Joint Inflammation
- Adjuvant Therapy
- Tumor Staging
- Spondyloarthritis
- Elderly Patients
- Total Hip Replacement
- Pathophysiology
- Echocardiography
- Biological Therapy
- Autoantibodies
- Eosinophils
- Radiotherapy
- Rehabilitation
- Guidelines
- Cardiovascular Risk
- Genetics
- Complications
- Management
- Quality of Life
- Inflammation
- Epidemiology
- Treatment
- Diagnosis
- Chemotherapy
- Clinical Practice Guidelines
- Surgical Management
- Asthma
- Clinical Trials
- Immunology
- Allergic Diseases
- Neoadjuvant Therapy
- Surgery
- Laparoscopic Surgery
- Preoperative Chemoradiotherapy
- Revision Surgery
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Treatment Guidelines
- Diagnostic Imaging
- Disease-Modifying Antirheumatic Drugs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology28▲ 3.8×79 topics
- Inflammation14▲ 3.7×40 topics
- Treatment13▲ 5.9×29 topics
- Quality of Life9▲ 3.5×34 topics
- Diagnosis8▲ 4.7×28 topics
- Management7▲ 4.8×20 topics
- Chemotherapy7▲ 5.2×20 topics
- Complications7▲ 7.3×16 topics
- Clinical Practice Guidelines6▲ 6.3×14 topics
- Genetics6▲ 4.8×9 topics
- Surgical Management6▲ 7.6×17 topics
- Cardiovascular Risk6▲ 9.9×6 topics
- Asthma6▲ 31×2 topics
- Guidelines5▲ 6.1×13 topics
- Clinical Trials5▲ 4.2×14 topics
- Rehabilitation5▲ 7.0×10 topics
- Immunology5▲ 25×2 topics
- Radiotherapy5▲ 6.5×10 topics
- Allergic Diseases4▲ 41×1 topic
- Eosinophils4▲ 41×1 topic
- Neoadjuvant Therapy4▲ 10×5 topics
- Autoantibodies4▲ 9.3×7 topics
- Surgery4▲ 5.8×8 topics
- Biological Therapy4▲ 35×2 topics
- Laparoscopic Surgery4▲ 17×4 topics
- Echocardiography4▲ 6.9×7 topics
- Preoperative Chemoradiotherapy3▲ 23×2 topics
- Pathophysiology3▲ 6.0×8 topics
- Revision Surgery3▲ 14×2 topics
- Total Hip Replacement3▲ 14×2 topics
- Ankylosing Spondylitis3▲ 61×1 topic
- Elderly Patients3▲ 10.0×4 topics
- Rheumatoid Arthritis3▲ 18×2 topics
- Spondyloarthritis3▲ 61×1 topic
- Treatment Guidelines3▲ 7.8×5 topics
- Tumor Staging3▲ 15×2 topics
- Diagnostic Imaging3▲ 15×4 topics
- Adjuvant Therapy3▲ 12×2 topics
- Disease-Modifying Antirheumatic Drugs3▲ 32×1 topic
- Joint Inflammation3▲ 32×1 topic
Which research topics does Medisch Centrum Leeuwarden publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies and Lung Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 4 works
- 2 Spondyloarthritis Studies and Treatments Rheumatology 3 works
- 3 Rheumatoid Arthritis Research and Therapies Rheumatology 3 works
- 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 5 Orthopedic Infections and Treatments Surgery 2 works
- 6 Colorectal Cancer Surgical Treatments Oncology 2 works
- 7 Structural Integrity and Reliability Analysis Mechanical Engineering 2 works
- 8 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 2 works
- 9 Total Knee Arthroplasty Outcomes Surgery 2 works
- 10 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medisch Centrum Leeuwarden's research output changed?
Output in 2018–2022 was 5% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Leeuwarden
- Fryske Akademy
- Stenden University of Applied Sciences
- Van Hall Larenstein University of Applied Sciences
- GGZ Friesland
- NHL University of Applied Sciences
- Radiotherapeutisch Instituut Friesland
- Friesland College
- CSK Food Enrichment (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.